Gandhar Oil Refinery India IPO: 10 key risk factors you should know before investing
Gandhar Oil Refinery India will open for subscription today and remain open until November 24. The company aims to raise ₹302 crore via the issuance of fresh equity shares, whereas existing shareholders and promoters will offload 11,756,910 shares, aggregating to ₹198.69 crore. The total size of the IPO was ₹500.69 crore.
The price band for the offer has been fixed at ₹160–169 per equity share with a face value of ₹02 each. The quota for retail investors in the Gandhar Oil Refinery India IPO has been fixed at 35% of the net offer. The QIB quota is fixed at 50%, while the quota for NII is reserved at 15%.
Gandhar Oil Refinery India is a leading manufacturer of white oils by revenue in the financial year 2023, including domestic and overseas sales, and is one of the top five players globally in terms of market share in the calendar year 2022. The company products are used as ingredients by leading Indian and global companies for the manufacture of end products for the consumer, healthcare, automotive, industrial, power, tyre, and rubber sectors. As of June 30, 2023, the company's products were sold in over 100 countries across the globe.
It catered to over 3,500 customers in the financial year 2023, including leading Indian and global companies such as Procter & Gamble (“P&G"), Unilever, Marico, Dabur, Encube, Patanjali Ayurved, Bajaj Consumer Care, Emami, and Amrutanjan Healthcare. Domestic brokerage firms have recommended a 'Subscribe' rating to the IPO. However, the following are some of the key risks outlined by the company in its RHP report: Promoter involvement in regulatory actions: The company promoters are involved in certain regulatory actions, including notices and summons with requests for information from the
. Read more on livemint.com
